Dr. Peters is President and Chief Executive Officer of Insytex and the Chairman of our Board of Directors since 1996.  From 2003 to 2009, Dr. Peters was Chairman and Chief Executive Officer of Adherex Technologies, a publicaly traded biotechnology company developing both molecularly targeted oncology therapeutics and classical chemotherapeutic agents. Dr. Peters has served on the faculty at Harvard University, Duke University and Wayne State University. He originated the solid tumor high-dose chemotherapy and bone marrow transplant program at the Dana-Farber Cancer Institute, and was Director of Bone Marrow Transplantation, Professor of Medicine at Duke University from 1984 to 1995 and was an Associate Director of the Cancer Center. He then became President, Director and CEO of the Karmanos Cancer Institute from 1995 to 2001 and was the Karmanos Distinguished Professor of Oncology. Simultaneously, he served as Associate Dean for Cancer at Wayne State University and Senior Vice President for Cancer Services at the Detroit Medical Center. In 2001, he organized the Institute for Strategic Analysis and Innovation at the Detroit Medical Center of which he served as President. Dr. Peters has three Bachelor's degrees (Biochemistry, Biophysics and Philosophy) from Pennsylvania State University, received his MPhil, MD and PhD degrees from Columbia University College of Physicians & Surgeons in New York and trained clinically at Harvard University Medical School's Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, MA. He is board certified in internal medicine and medical oncology. Dr. Peters earned his MBA at the Duke University Fuqua School of Business.

William P. Peters MD PhD